Salivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendations

Aurore Surun; Dominik T. Schneider; Andrea Ferrari; Teresa Stachowicz-Stencel; Jelena Rascon; Anna Synakiewicz; Abbas Agaimy; Kata Martinova; Denis Kachanov; Jelena Roganovic; Ewa Bien; Gianni Bisogno; Ines B. Brecht; Frédéric Kolb; Juliette Thariat; Antoine Moya-Plana; Daniel Orbach

doi:10.1002/pbc.29058

Salivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendations

Aurore Surun, Dominik T. Schneider, Andrea Ferrari, Teresa Stachowicz-Stencel, Jelena Rascon, Anna Synakiewicz, Abbas Agaimy, Kata Martinova, Denis Kachanov, Jelena Roganovic, Ewa Bien, Gianni Bisogno, Ines B. Brecht, Frédéric Kolb, Juliette Thariat, Antoine Moya-Plana, Daniel Orbach

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

18 Citations (Scopus)

Résumé

Salivary gland carcinomas (SGCs) are rare during childhood and adolescence. Consequently, no standardized recommendations for the diagnosis and therapeutic management of pediatric SGC are available, and pediatric oncologists and surgeons generally follow adult guidelines. Complete surgical resection with adequate margins constitutes the cornerstone of treatment. However, the indications and modalities of adjuvant therapy remain controversial and may be challenging in view of the potential long-term toxicities in the pediatric population. This paper presents the consensus recommendations for the diagnosis and treatment of children and adolescents with SGCs, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) within the EU-funded PARTNER project (Paediatric Rare Tumours Network - European Registry).

langue originale	Anglais
Numéro d'article	e29058
journal	Pediatric Blood and Cancer
Volume	68
Numéro de publication	S4
Les DOIs	https://doi.org/10.1002/pbc.29058
état	Publié - 1 juin 2021

Accès au document

10.1002/pbc.29058

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Surun, A., Schneider, D. T., Ferrari, A., Stachowicz-Stencel, T., Rascon, J., Synakiewicz, A., Agaimy, A., Martinova, K., Kachanov, D., Roganovic, J., Bien, E., Bisogno, G., Brecht, I. B., Kolb, F., Thariat, J., Moya-Plana, A., & Orbach, D. (2021). Salivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendations. Pediatric Blood and Cancer, 68(S4), Article e29058. https://doi.org/10.1002/pbc.29058

@article{e3b60f3e31fb4df7ba9a93da83581547,

title = "Salivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendations",

abstract = "Salivary gland carcinomas (SGCs) are rare during childhood and adolescence. Consequently, no standardized recommendations for the diagnosis and therapeutic management of pediatric SGC are available, and pediatric oncologists and surgeons generally follow adult guidelines. Complete surgical resection with adequate margins constitutes the cornerstone of treatment. However, the indications and modalities of adjuvant therapy remain controversial and may be challenging in view of the potential long-term toxicities in the pediatric population. This paper presents the consensus recommendations for the diagnosis and treatment of children and adolescents with SGCs, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) within the EU-funded PARTNER project (Paediatric Rare Tumours Network - European Registry).",

keywords = "EXPeRT/PARTNER, adolescents and young adults, children, diagnosis, recommendations, salivary gland carcinoma, therapy",

author = "Aurore Surun and Schneider, {Dominik T.} and Andrea Ferrari and Teresa Stachowicz-Stencel and Jelena Rascon and Anna Synakiewicz and Abbas Agaimy and Kata Martinova and Denis Kachanov and Jelena Roganovic and Ewa Bien and Gianni Bisogno and Brecht, {Ines B.} and Fr{\'e}d{\'e}ric Kolb and Juliette Thariat and Antoine Moya-Plana and Daniel Orbach",

note = "Publisher Copyright: {\textcopyright} 2021 Wiley Periodicals LLC",

year = "2021",

month = jun,

day = "1",

doi = "10.1002/pbc.29058",

language = "English",

volume = "68",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

number = "S4",

}

Surun, A, Schneider, DT, Ferrari, A, Stachowicz-Stencel, T, Rascon, J, Synakiewicz, A, Agaimy, A, Martinova, K, Kachanov, D, Roganovic, J, Bien, E, Bisogno, G, Brecht, IB, Kolb, F, Thariat, J, Moya-Plana, A & Orbach, D 2021, 'Salivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendations', Pediatric Blood and Cancer, VOL. 68, Numéro S4, e29058. https://doi.org/10.1002/pbc.29058

TY - JOUR

T1 - Salivary gland carcinoma in children and adolescents

T2 - The EXPeRT/PARTNER diagnosis and treatment recommendations

AU - Surun, Aurore

AU - Schneider, Dominik T.

AU - Ferrari, Andrea

AU - Stachowicz-Stencel, Teresa

AU - Rascon, Jelena

AU - Synakiewicz, Anna

AU - Agaimy, Abbas

AU - Martinova, Kata

AU - Kachanov, Denis

AU - Roganovic, Jelena

AU - Bien, Ewa

AU - Bisogno, Gianni

AU - Brecht, Ines B.

AU - Kolb, Frédéric

AU - Thariat, Juliette

AU - Moya-Plana, Antoine

AU - Orbach, Daniel

PY - 2021/6/1

Y1 - 2021/6/1

N2 - Salivary gland carcinomas (SGCs) are rare during childhood and adolescence. Consequently, no standardized recommendations for the diagnosis and therapeutic management of pediatric SGC are available, and pediatric oncologists and surgeons generally follow adult guidelines. Complete surgical resection with adequate margins constitutes the cornerstone of treatment. However, the indications and modalities of adjuvant therapy remain controversial and may be challenging in view of the potential long-term toxicities in the pediatric population. This paper presents the consensus recommendations for the diagnosis and treatment of children and adolescents with SGCs, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) within the EU-funded PARTNER project (Paediatric Rare Tumours Network - European Registry).

AB - Salivary gland carcinomas (SGCs) are rare during childhood and adolescence. Consequently, no standardized recommendations for the diagnosis and therapeutic management of pediatric SGC are available, and pediatric oncologists and surgeons generally follow adult guidelines. Complete surgical resection with adequate margins constitutes the cornerstone of treatment. However, the indications and modalities of adjuvant therapy remain controversial and may be challenging in view of the potential long-term toxicities in the pediatric population. This paper presents the consensus recommendations for the diagnosis and treatment of children and adolescents with SGCs, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) within the EU-funded PARTNER project (Paediatric Rare Tumours Network - European Registry).

KW - EXPeRT/PARTNER

KW - adolescents and young adults

KW - children

KW - diagnosis

KW - recommendations

KW - salivary gland carcinoma

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=85109117883&partnerID=8YFLogxK

U2 - 10.1002/pbc.29058

DO - 10.1002/pbc.29058

M3 - Article

C2 - 34174160

AN - SCOPUS:85109117883

SN - 1545-5009

VL - 68

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - S4

M1 - e29058

ER -